title: The Future of Nanoparticle-Directed Venous Therapy.
abstract: Nanoparticles, structures of less than 200 nm capable of delivering pharmacotherapeutics to sites of disease, have shown great promise for the treatment of many disease states. While no nanoparticle therapies for deep vein thrombosis are currently approved by the Food and Drug Administration, many of the unique features of these therapies have the potential to treat both deep vein thrombosis and its most significant sequela, postthrombotic syndrome, while limiting the hemorrhagic complications of current antithrombotic therapies. Nanoparticles are complex structures with several important variables that must be considered to engineer effective therapies. This article will review the structure and engineering of nanoparticles, as well as promising molecular targets for future investigation.
authors.affiliation: Section of General Surgery, Department of Surgery, University of Michigan, Ann Arbor, Michigan.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Jacobs
authors.affiliation: Section of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, Michigan.
authors.forename: Chandu
authors.initials: C
authors.lastname: Vemuri
keywords: deep vein thrombosis; interventional radiology; nanoparticle therapy